Hyperthermic intrathoracic/intraperitoneal chemotherapy versus conventional intrapleural/intraperitoneal chemotherapy for the malignant effusion: a multi-center randomized clinical trial [PDF]
International Journal of Hyperthermia, 2023 Objective To compare the efficacy and safety of hyperthermic intrathoracic/intraperitoneal chemotherapy versus conventional intrapleural/intraperitoneal chemotherapy in the treatment of malignant pleural or peritoneal effusion.Methods A randomized ...
Lili Liu +14 more
doaj +2 more sources
Cytoreduction with hyperthermic intraperitoneal chemotherapy: An anaesthetic challenge [PDF]
Indian Journal of Anaesthesia, 2014 Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy plays a considerable role as a treatment modality in surgical oncology in western countries. The advantage of this procedure is that the heated chemotherapeutic agent is circulated in the abdominal cavity and achieves high peritoneal concentration with limited systemic ...
Kavita Murughan +2 more
openaire +4 more sources
The Registry of Hyperthermic Intraperitoneal Chemotherapy – A Mandatory Step in the Development of this Therapeutic Approach in Romania [PDF]
Applied Medical Informatics, 2015 Multicenter/institutional studies have been the basis for the confirmation of Hyperthermic Intraperitoneal Chemotherapy as a therapeutic option for selected patients with Peritoneal Surface Malignancies.
Corneliu LUNGOCI +5 more
doaj +1 more source
Effect of Cilastatin on Cisplatin-Induced Nephrotoxicity in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy [PDF]
, 2021 Cisplatin is one of the most widely used chemotherapeutic agents in oncology, although its nephrotoxicity limits application and dosage. We present the results of a clinical study on prophylaxis of cisplatin-induced nephrotoxicity in patients with ...
Vasquez-Jimenez, Wenceslao +36 more
core +2 more sources
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis: our initial experience of implementation and detailed technique [PDF]
Ķazaķstannyṇ Klinikalyķ Medicinasy, 2019 Objective: The aim of this study is to present our initial implementation experience in peritoneal carcinomatosis treatment and the technical details of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the light of current ...
Talgat Uskenbayev +4 more
doaj +1 more source
Pleura and Peritoneum, 2022 Cisplatin is commonly used during intraperitoneal chemotherapy however has well-established nephrotoxic side-effects. Sodium thiosulfate is often added to cisplatin-based hyperthermic intraperitoneal chemotherapy (HIPEC) protocols to mitigate this ...
Alonso Anais +4 more
doaj +1 more source
Peritoneal Canceromatosis in Malignant Tumors of Various Localizations. Achievements and Prospects
Креативная хирургия и онкология, 2021 Peritoneal carcinomatosis is viewed by many experts as a terminal illness with an unfavourable course and prognosis. Existing therapies are controversial and exhibit ambiguous efficacy.
Sh. Kh. Gantsev +3 more
doaj +1 more source
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Systematic Review [PDF]
, 2022 Background: Combined treatment modality of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is emerging as an alternative option for colorectal peritoneal metastases, but there is ambiguity regarding patient selection, treatment ...
Norbert Garcia-Henriquez +13 more
core +1 more source
Gynecologic Oncology Reports, 2020 Sertoli Leydig cell tumor (SLCT) is a rare sex-cord stromal tumor of the ovary that generally has a benign course. Here, we report an unusual case of recurrent, metastatic SLCT and its unique management with a combination of cytoreductive surgery ...
Nicholas K. Larsen +4 more
doaj +1 more source
Is Cytoreductive Surgery Possible in Cervical Cancer Peritoneal Carcinomatosis?
Clinical Medicine Insights: Oncology, 2021 Background: The number of cases of cervical cancer with recurrence and peritoneal carcinomatosis is limited. In our study, we aimed to present the results of cytoreductive surgery hyperthermic intraperitoneal chemotherapy treatment and its 3-year early ...
Ozgul Duzgun, Murat Kalin
doaj +1 more source